← Leaderboards
Jason Weber
Washington University
$7,135,661
Attributed
$8,505,319
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $795K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,505,319 · 12
By mechanism
R01$8,471,265 · 6
P41$34,054 · 6
Top collaborators
- David H. Gutmann4 shared
- David R Piwnica-Worms4 shared
- Michael H Tomasson2 shared
Most similar at Washington University
Same institution · by research overlap
- David H. Gutmann$29,869,613
- Jean E Schaffer$33,853,860
- Susan K Dutcher$55,113,689
- Megan T Baldridge$11,493,915
- Reid Townsend$629,608
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsProteinsSignal TransductionTumorGenesComplexAffectTumor Suppressor ProteinsIn VitroPreventPathway InteractionsIn VivoCellsTp53 GeneCell NucleolusCell GrowthMutantGrowthRibosomesBiologyGeneticInhibitor/AntagonistProtein ExpressionBasic Science
Grant awards (31)
Antagonistic role of ARF and ADAR1 in triple-negative breast cancer$418,181
R01 · FY2025 · CA · contact PI
Antagonistic role of ARF and ADAR1 in triple-negative breast cancer$397,274
R01 · FY2024 · CA · contact PI
Antagonistic role of ARF and ADAR1 in triple-negative breast cancer$412,015
R01 · FY2023 · CA · contact PI
Antagonistic role of ARF and ADAR1 in triple-negative breast cancer$423,560
R01 · FY2022 · CA · contact PI
REGULATION OF TUMOR SUPPRESSION BY ARF$348,844
R01 · FY2020 · CA · contact PI
REGULATION OF TUMOR SUPPRESSION BY ARF$338,377
R01 · FY2019 · CA · contact PI
REGULATION OF TUMOR SUPPRESSION BY ARF$348,844
R01 · FY2018 · CA · contact PI
REGULATION OF TUMOR SUPPRESSION BY ARF$348,844
R01 · FY2017 · CA · contact PI
REGULATION OF TUMOR SUPPRESSION BY ARF$348,844
R01 · FY2016 · CA · contact PI
ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY$305,938
R01 · FY2014 · CA
ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY$315,400
R01 · FY2013 · CA
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK$305,938
R01 · FY2012 · CA · contact PI
REGULATION AND ROLE OF MTOR IN NEUROFIBROMIN GROWTH CONTROL$404,112
R01 · FY2011 · CA · contact PI
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK$305,938
R01 · FY2011 · CA · contact PI
CHARACTERIZATION OF P53-INDEPENDENT ARF PATHWAY$12,820
P41 · FY2011 · RR · contact PI
REGULATION AND ROLE OF MTOR IN NEUROFIBROMIN GROWTH CONTROL$469,859
R01 · FY2010 · CA · contact PI
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK$315,400
R01 · FY2010 · CA · contact PI
CHARACTERIZATION OF P53-INDEPENDENT ARF PATHWAY$9,710
P41 · FY2010 · RR · contact PI
REGULATION AND ROLE OF MTOR IN NEUROFIBROMIN GROWTH CONTROL$372,952
R01 · FY2009 · CA · contact PI
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK$315,400
R01 · FY2009 · CA · contact PI
CHARACTERIZATION OF P53-INDEPENDENT ARF PATHWAY$8,730
P41 · FY2009 · RR · contact PI
REGULATION AND ROLE OF MTOR IN NEUROFIBROMIN GROWTH CONTROL$341,561
R01 · FY2008 · CA · contact PI
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK$315,400
R01 · FY2008 · CA · contact PI
CHARACTERIZATION OF P53-INDEPENDENT ARF PATHWAY$531
P41 · FY2008 · RR · contact PI
Characterization of p53-independent ARF pathway$253,876
R01 · FY2007 · GM · contact PI
CHARACTERIZATION OF P53-INDEPENDENT ARF PATHWAY$1,130
P41 · FY2007 · RR · contact PI
Characterization of p53-independent ARF pathway$261,458
R01 · FY2006 · GM · contact PI
CHARACTERIZATION OF P53-INDEPENDENT ARF PATHWAY$1,133
P41 · FY2006 · RR · contact PI
Characterization of p53-independent ARF pathway$267,750
R01 · FY2005 · GM
Characterization of p53-independent ARF pathway$267,750
R01 · FY2004 · GM
Characterization of p53-independent ARF pathway$267,750
R01 · FY2003 · GM